Loading...

Chinese Journal of Blood Purification

    12 March 2020, Volume 19 Issue 03 Previous Issue    Next Issue
    The enlightenment from successful application of hypoxia inducible factor-prolyl hydroxylase inhibitor (HIF-PHI) in renal anemia
    2020, 19 (03):  145-148.  doi: 10.3969/j.issn.1671-4091.2020.03.001
    Abstract ( 386 )   PDF (366KB) ( 1214 )  
    【Abstract】Studies of the erythropoietin(EPO) regulation, an important pathophysiological response to hypoxia, have led to the discovery of oxygen sensing and adapting system. This discovery has provided a theoretical basis for the treatment of EPO deficiency-related diseases. The development of hypoxia inducible factor-prolyl hydroxylase inhibitor (HIF- PHI) through the targeting of prolyl hydroxylase domain (PHD) is a type of translational medicine based on this discovery. HIF-PHIs have used clinically for the treatment of renal anemia. However, the effects of HIF-PHI on kidney and its related diseases are largely unhnown. In this paper, we summarize the potential effects of HIF-PHI on anemia, kidney diseases and CKD-related cardiovascular disease.

    Metrics
    Inflammatory status and its impact on renal anemia treatment in chronic kidney disease patients
    2020, 19 (03):  149-152.  doi: 10.3969/j.issn.1671-4091.2020.03.002
    Abstract ( 360 )   PDF (369KB) ( 1002 )  
    【Abstract】Renal anemia is a common complication of chronic kidney disease (CKD). CKD patients often complicate with chronic inflammatory status, which can aggravate the renal anemia by interfering with the production of erythrocytes, reactivity to erythropoietin (EPO) and iron homeostasis. Traditional therapies have limited effects on renal anemia. Hypoxia-inducible factor (HIF) plays an important role in the regulation of inflammatory status. Hypoxia-inducible factors-prolyl hydroxylase inhibitor (HIF-PHI) can improve bone marrow microenvironment, leading to the promotion of EPO production, inhibition of hepcidin expression, increase of iron absorption and utilization, and alleviation of inflammatory injury to kidney and renal anemia. In this review, we summarize the recent progress in the mechanism of inflammatory status on anemia and its treatment in CKD patients.
    Metrics
    The etiology and management strategy of low responsiveness to erythropoiesis stimulatory agent
    2020, 19 (03):  153-156.  doi: 10.3969/j.issn.1671-4091.2020.03.003
    Abstract ( 408 )   PDF (388KB) ( 1090 )  
    【Abstract】Anemia is a common complication of chronic kidney disease (CKD). Erythropoietin (EPO) significantly improves the anemia status of CKD patients. However, about 5~10% of the patients failed to reach the required hemoglobin level despite the use of a large dose of EPO, which is clinically considered to have low responsiveness to erythropoietin stimulating agent (ESA). According to the recent understanding, iron deficiency, inflammation and infection, severe secondary hyperparathyroidism, inadequate dialysis, antigen-mediated pure erythrocyte aplastic anemia, are the complications leading to low responsiveness to ESA. Clinically, regular diagnostic processes should be conducted to find out the cause of this disease situation and the appropriate management.
    Metrics
    A review of iron metabolism, laboratory assessment and strategy for iron management
    2020, 19 (03):  157-160.  doi: 10.3969/j.issn.1671-4091.2020.03.004
    Abstract ( 427 )   PDF (414KB) ( 1238 )  
    【Abstract】Iron is a vital trace element for humans. The amount of iron in the body has to be maintained in an ideal range. The absorption of dietary iron and the transport of iron are complex processes critical for iron homeostasis. The reticuloendothelial system is responsible for iron recycling through phagocytosis of the erythrocytes. Hepcidin is a liver-derived peptide hormone and an important regulator of iron metabolism. This hormone acts in many target tissues and regulates iron level in the body through a negative feedback mechanism. Serum ferritin is a fundamental index to reflec iron metabolism situation in the body. In chronic inflammatory conditions, higher thresholds of ferritin concentration and transferrin saturation, and other laboratory examinations such as soluble and serum transferrin receptors and hepcidin are required for the evaluation of this disease conditions. The best evidences and experiences should be referred in the determination of the iron supplementation strategy for iron deficiency in inflammation and chronic kidney disease.
    Metrics
    Low protein rice plus low phosphorus whey improves hyperphosphatemia in maintenance hemodialysis patients: a self- controlled study
    2020, 19 (03):  161-164.  doi: 10.3969/j.issn.1671-4091.2020.03.005
    Abstract ( 378 )   PDF (371KB) ( 857 )  
    【Abstract】Objective To study the efficacy and safety of low protein rice plus low phosphorus whey on hyperphosphatemia in hemodialysis patients. Methods The hemodialysis patients who had average serum phosphorus of ≥1.78 mmol/L for three consecutive months were enrolled in this self-controlled trial. Patients received low phosphorus diet instruction for 4 weeks as baseline, followed by change of the staple foods to the same amount of low protein rice for 10 weeks. The difference of protein intake between the low protein rice and staple foods was replaced by low phosphorus whey. Then the patients reverted to staple foods for 8 weeks. Serum phosphorus, calcium, intact parathyroid hormone (iPTH), serum albumin and nutritional status before and after dietary changes were observed and analyzed. Throughout the trial, dialysis treatment remained unchanged; appropriate adjustment of oral phosphorous binding agent, active vitamin D or calcimimetic treatment based on the results of calcium, phosphorus and iPTH were allowed. The changes of these medications were recorded and analyzed. Results A total of 29 patients completed the study. Serum phosphorus at the beginning was 2.15±0.28 mmol/L. After 4 weeks of low phosphorus diet instruction, serum phosphorus decreased but without statistical significance. After 2 weeks of low protein rice plus low phosphate whey, there were no significant differences in calorie and protein intake, while phosphorus intake was significantly reduced (t=5.132, t=- 2.200, P<0.001, P=0.037, respectively); serum phosphorus reduced to 1.82 ± 0.45mmol/L, which was significantly lower than the baseline value (t=-2.200, P=0.037). This effect continued until the end of 10 weeks (t=-2.011, P=0.048, compared to baseline value). After reverted to staple foods for 8 weeks in which calorie and protein intake had no significant differences, phosphorus intake increased significantly (t=-2.577, P=0.016); serum phosphorus increased significantly compared to that during food intervention at 10th week (t=2.979, P=0.006) and had no significant difference from baseline value. In addition, serum albumin increased significantly (t=5.376, P<0.001). There were no changes in serum calcium and iPTH levels, dialysis regimen and phosphorus-binding agents throughout the study. Conclusion For hemodialysis patients, low protein rice plus low phosphorus whey can effectively reduce phosphorus intake, decrease serum phosphorus level, and improve serum albumin on the basis of enough calorie and protein intake.
    Metrics
    Determination of target body weight of peritoneal dialysis patients by bioimpedance: a randomized controlled clinical study
    2020, 19 (03):  165-169.  doi: 10.3969/j.issn.1671-4091.2020.03.006
    Abstract ( 259 )   PDF (427KB) ( 735 )  
    【Abstract】Objective To verify the clinical effectiveness and safety of using bioimpedance to determine the target body weight of peritoneal dialysis (PD) patients. Methods A total of 75 PD patients were randomly divided into traditional method group and body composition monitor (BCM) group. BCM group used the formula: target body weight = measured body weight - over hydration (OH) + 2 kg, to guide patient volume management. After 6 months, changes of blood pressure, edema degree and brain natriuretic peptide (BNP) were compared between the two groups. Results The OH value by BCM was positively correlated with edema degree (r=0.366, P=0.001), defined daily doses (DDDs) of blood pressure medications (r=0.440, P<0.001), systolic pressure (r=0.494, P<0.001), diastolic pressure (r=0.414, P<0.001), left ventricular end diastolic dimension (r=0.591, P<0.001) and BNP (r=0.615, P<0.001), and was negatively correlated with albumin (r=-0.354, P=0.002). In BCM group after 6 months, body weight (60.4±10.6 vs. 59.6±10.2; t=2.988, P=0.005), systolic blood pressure (136.5±23.9 vs. 126.9±20.3; t=2.238, P= 0.033) and the patients with moderate or higher than moderate edema (46.9% vs. 37.5%; χ2=15.469, P<0.001) decreased; these changes were not observed in control group. Conclusion BCM can be used to help determine target body weight of PD patients.
    Metrics
    Effect of serum thyroid hormone abnormalities on survival in patients undergoing maintenance hemodialysis
    2020, 19 (03):  170-173.  doi: 10.3969/j.issn.1671-4091.2020.03.007
    Abstract ( 313 )   PDF (475KB) ( 790 )  
    【Abstract】Objective To examine the changes of serum thyroid hormones and their effect on survival in patients undergoing maintenance hemodialysis dialysis (MHD). Methods Baseline data including demographic information, thyroid hormone tests, and clinical biochemistry were collected from MHD patients treated in Peking University Third Hospital in November 2011 and a fivEyear follow-up was then performed. The patients were divided into three groups: euthyroid, low triiodothyronine (T3) syndrome, and hypothyroidism. OnEway ANOVA was used to compare the differences among groups. Multivariate regression analysis was performed to examine the affecting factors for serum free T3 (FT3). Cox proportional hazards modeling was used to analyze the association between serum thyroid hormones and all-cause mortality. Results A total of 121 patients were included in this study, of whom 78 (64.50%) had low T3 syndrome and 15 (12.40%) had hypothyroidism. In patients in low T3 syndrome group or hypothyroidism group, the proportion of female (χ2=10.082, P=0.006) and older age (F=4.899, P=0.009) were higher but body weight (F=4.129, P=0.019) and serum prealbumin (F=6.233, P=0.003) were lower, as compared with those in euthyroid group. Multivariate regression analysis showed that serum CRP and prealbumin were the independent influence factors on serum FT3 level (β =-0.266, P=0.004; β=0.250, P=0.022). COX regression analysis showed that serum FT3 was an independent risk factor for death in MHD patients (HR 0.343, 95% CI 0.130~0.906; P=0.031) but TSH was not the risk factor (HR 0.997, 95%CI 0.969~1.026; P=0.831) after adjusting sex, age, diabetes mellitus, dialysis vintage and hemoglobin. Conclusions Our study indicates that low T3 syndrome is a dominant modality of thyroid dysfunction, and serum FT3 but not TSH can independently predict the all- cause mortality in MHD patients.
    Metrics
    A multicenter study of the relationship between fluid status assessed by bioimpedance analysis and blood pressure in maintenance hemodialysis patients#br#
    2020, 19 (03):  174-178.  doi: 10.3969/j.issn.1671-4091.2020.03.008
    Abstract ( 282 )   PDF (431KB) ( 776 )  
    【Abstract】Objective Bioimpedance analysis (BIA) was used to evaluate volume load and the blood pressure (BP) at home was measured at the same time to study the relationship between fluid status and BP in maintenance hemodialysis (MHD) patients. Methods A total of 113 MHD patients in the 7 blood purification centers in Beijing were enrolled in this study. BIA was used to measure the overhydration (OH) status and to calculate the weekly timEaveraged overhydration (wTAOH). The patients were then assigned into 4 groups: the dehydration group (group 1, wTAOH less than - 0.25L), the normohydration group (group 2, ≤- 0.25L
    wTAOH ≤1.25L), the overhydration group (group 3, <1.25L wTAOH ≤2.8L), and severe overhydration group (group 4, wTAOH >2.8L). The home systolic blood pressure (HSBP) and the related parameters were compared among the 4 groups. The patients were divided into 3 categories based on the HSBP in a week: class 1 (HSBP <135mmHg), class 2 (≤135mmHg HSBP <160mmHg) and class 3 (HSBP≥160mmHg). Pearson correlation analysis was used to investigate the relationship between wTAOH and HSBP. Results BIA found that the rates of MHD patients with overhydration (group 3) and severe overhydration (group 4) were 28.3% and 18.6%, respectively; the rates of the patients with normohydration (group 2) and dehydration (group 1) were 40.7% and 12%, respectively. The MHD patients in class 1(HSBP <135mmHg), class 2 (≤ 135mmHg HSBP <160mmHg) and class 3 (HSBP >160mmHg) were 30.0%, 41.6% and 28.4%, respectively. Pearson correlation revealed that wTAOH was positively correlated with HSBP (r=0.200, P=0.033). The HSBP was higher in group 4 than in groups 2 and 3 (156.0±16.9 vs. 143.0±17.5mmHg, t=2.773, P=0.007 for group 4 vs. group 2; 156.0±16.9 vs. 145.7±18.5mmHg, t=2.051, P=0.043 for group 4 vs. group 3) but had no statistical significance between groups 4 and 1. Conclusion Overhydration is prevalent in MHD patients. BP is positively correlated with overhydration. However, BP cannot accurately reflect volume load status, especially the normohydration and dehydration status, in MHD patients.
    Metrics
    Effect of oxygen therapy combined with hypothermic hemodialysis on Intradialytic hypotension
    2020, 19 (03):  179-182.  doi: 10.3969/j.issn.1671-4091.2020.03.009
    Abstract ( 311 )   PDF (422KB) ( 797 )  
    【Abstract】Objective To investigate the effect of oxygen therapy combined with Hemodialysis (HD) on dialysis hypotension (IDH). Methods Eighty-four hemodialysis patients were selected and divided into two stages by self-control method. Stage I was treated with simple hypothermic hemodialysis, stage II oxygen therapy combined with hypothermic hemodialysis for 8 weeks. Two phases monitor the frequency of hypotension during dialysis and detect two-stage biochemical and blood gas analysis parameters. Results Oxygen therapy combined with hypothermic hemodialysis significantly reduced the number of episodes of IDH (from 3.16±2.57 to 1.98±1.84, t=4.030, P=0.001). There was a small difference in serum albumin between the two stages but it was statistically significant [stages I and II were (33.2±2.9) and (32.3±2.5)g/L, t=2.154, P=0.033]. The blood gas analysis showed that compared with the no oxygen therapy stage, Oxygen therapy significantly reduced TCO2 (t =8.765, P<0.001) and HCO3- (t=10.820, P<0.001) and increased pH (t=18.330, P<0.001). Conclusion Oxygen therapy combined with hypothermic hemodialysis has a better effect on IDH and can maintain the metabolic acid-base balance in hemodialysis to a certain extent.
    Metrics
    Changes of plasma PTX3 in maintenance hemodialysis patients and their correlation with cardiovascular disease risks
    2020, 19 (03):  183-186.  doi: 10.3969/j.issn.1671-4091.2020.03.010
    Abstract ( 277 )   PDF (406KB) ( 772 )  
    【Abstract】Objective To investigate the relationship between changes of plasma positive pentraxin 3 (PTX3) and cardiovascular disease risks in maintenance hemodialysis (MHD) patients. Methods Eighty patients undergoing MHD in our hospital from March 2019 to July 2019 were enrolled as the experimental group. All patients received hemodialysis for ≥6 months. According to the presence or absence of cardiovascular disease, they were assigned into cardiovascular disease (CVD) group or non- cardiovascular disease (NCVD) group. Twenty individuals with healthy physical examination in our hospital were enrolled as the control group. Plasma PTX3 was determined by enzyme-linked immunosorbent assay. Spearman correlation was used to analyze the relationship between PTX3 and high-sensitivity C-reactive protein (hsCRP), troponin T (cTnT), and hemoglobin (Hb). Risk factors for CVD were analyzed by two- class logistic regression. Results Plasma PTX3 level was significantly higher in the MHD group than in the healthy control group (t=-7.346, P<0.001), as well as in the CVD group than in the NCVD group (t=-4.208, P<0.001). Conclusion Plasma PTX3 was higher in MHD patients than in normal subjects, and was significantly higher in MHD patients complicated with CVD than those without CVD. Age (OR=1.070, 95% CI: 1.003- 1.141, P=0.039), cTnT (OR=1.019, 95% CI: 1.004-1.035, P=0.013), and PTX3 (OR=4.338, 95% CI: 1.160-16.608, P=0.029) were the independent risk factors for CVD in MHD patients.
    Metrics
    Impact of high-flux dialysis on 7-year secondary patency rate of autologous arteriovenous fistula in hemodialysis patients
    2020, 19 (03):  187-190.  doi: 10.3969/j.issn.1671-4091.2020.03.011
    Abstract ( 314 )   PDF (440KB) ( 942 )  
    【Abstract】Objective This study was conducted to investigate the impact of high-flux dialysis on lifespan of the autologous arteriovenous fistula in patients undergoing maintenance hemodialysis (MHD). Methods A total of 491 patients with regular hemodialysis at the Blood Purification Center of Guangdong Provincial People's Hospital from 2012 to 2019 were enrolled in this study. The propensity score matching method matched high-flux dialysis group (n=54) and low-flux dialysis group (n=54). The 7-year secondary patency rate of arteriovenous fistula was compared between the two groups. Results Kaplan-Meier survival analysis
    showed no statistical difference in the 7-year secondary patency rate of autologous arteriovenous fistula between high- flux dialysis group and low- flux dialysis group [before matching: 87.9% vs. 84.3%, HR (95% CI) =0.834 (0.449~1.548), P=0.566; after matching: 91.2% vs. 82.1%, HR (95% CI) =0.836 (0.224~3.120), P=0.790]. Conclusion The high- flux dialysis mode had no significant impact on the lifespan of arteriovenous fistula in MHD patients.
    Metrics
    Factors influencing the choice of automated peritoneal dialysis mode in uremic patients: a literature review
    2020, 19 (03):  191-193.  doi: 10.3969/j.issn.1671-4091.2020.03.012
    Abstract ( 311 )   PDF (359KB) ( 891 )  
    【Abstract】Automated peritoneal dialysis (APD) is considered to be advantageous over continuous ambulatory peritoneal dialysis (CAPD). APD is widely used in developed countries, but the development of APD is relatively slow in China. This article reviews the factors influencing the use of APD mode in uremic patients from the aspects of medical, socio-economic, personal and family factors, in order to provide an alternative dialysis modality for uremic patients and medical staff, the information about the adjustment of national medical insurance policy, and the necessity of a social support system. The development and progress of APD will give uremic patients a better and more appropriate dialysis option, facilitating to return to society and to have a higher quality of life.
    Metrics
    Application of the simplified medication adherence questionnaire in improving treatment compliance with oral phosphorus-binding agent in maintenance hemodialysis patients#br#
    2020, 19 (03):  197-200.  doi: 10.3969/j.issn.1671-4091.2020.03.014
    Abstract ( 250 )   PDF (411KB) ( 845 )  
    【Abstract】Objective To investigate the effect of the simplified medication adherence questionnaire (SMAQ) in improving treatment compliance with oral phosphorus binding-agent in maintenance hemodialysis (MHD) patients. Methods A total of 95 MHD patients complicated with hyperphosphatemia and admitted to Dandong First Hospital in the period from January 2018 to December 2018 were enrolled in this study. According to the random number table method, they were divided into the SMAQ group (n=46) and the control group (n=49). Both groups were treated with oral phosphorus binding agent and routine nursing. Patients in the SMAQ group were treated with SMAQ during nursing process and the intervention lasted 3 months. Serum phosphorus (SP) control rate, serum calcium (SCa), serum phosphorus (SP), calcium-phosphorus product (Ca×P), intact parathyroid hormone (iPTH) and adverse reactions were compared between the groups before and after the intervention. Results After the intervention, the SMAQ scores were significantly improved (χ2=32.687, P<0.001), SP control rate was higher in the SMAQ group than in the control group (χ2=28.599, P<0.001), SP (t=-2.956, P=0.004) and Ca×P value (t=-2.744, P=0.007) were lower in the SMAQ group than in the control group, and iPTH was also lower in the SMAQ group than in the control group but without statistical significance (430.2 pg/ml vs. 543.8 pg/ml; t=-1.287, P=0.201). SCa was similar between the two groups (t= -0.261, P=0.795). Conclusion The application of SMAQ among MHD patients can effectively improve their compliance with oral phosphorus-binding agent.

    Metrics
    Contractual management model improved fluid status in peritoneal dialysis patients
    2020, 19 (03):  201-204.  doi: 10.3969/j.issn.1671-4091.2020.03.015
    Abstract ( 225 )   PDF (433KB) ( 730 )  
    【Abstract】Objective To evaluate the effectiveness of contractual management on fluid status in peritoneal dialysis (PD) patients. Methods Patients with over hydration screened by human body composition monitor and met the inclusion criteria from the Peritoneal Dialysis Center of the Second Affiliated Hospital of Harbin Medical University were randomly assigned into two groups. Patients in control group received routine health care and those in experimental group adopted contract management on the basis of routine health education and signed a health care agreement. The volume management behavior, volume status, dialysis related indicators and laboratory examination results were compared before intervention and after intervention for 6 months. Results In experiment group after the intervention for 6 months, body weight decreased as compared with that in control group (t=-3.201, P=0.002), the times of blood pressure measurement per week increased (Z=-2.265, P=0.024), liquid intake decreased (Z=-2.285, P=0.022), and over hydration parameters improved (t=-3.623, P=0.001). Conclusion Contractual management is a management mode that obviously restricts the volume management of PD patients. This management can improve the volume management behavior and volume status in PD patients.
    Metrics
    The application of self-made home management manual for renal anemia in peritoneal dialysis patients
    2020, 19 (03):  205-208.  doi: 10.3969/j.issn.1671-4091.2020.02.016
    Abstract ( 75 )   PDF (417KB) ( 244 )  
    【Abstract】Objective To design a home management manual for renal anemia in order to promote the compliant use of erythropoietin (EPO) and the rate of targeted hemoglobin level in peritoneal dialysis (PD) patients. Methods A total of 100 PD patients regularly followed up in our PD center from January 2017 to December 2017 were enrolled in this study. A professional home management manual for renal anemia was designed according to the rate of targeted hemoglobin level and the status of EPO use. Results The rates of compliant use of EPO (83% vs. 17%) and targeted hemoglobin level (84% vs. 16%) in the 100 PD patients were significantly increased after application of the home management manual for renal anemia for 9 months, as compared with those before the intervention. The rates of compliant use of EPO and targetd hemoglobin level were significantly higher after the intervention for 6 and 9 months than those after the intervention for 3 months (after 6 months: χ2=4.204 and 17.195 respectively, P=0.040 and <0.001 respectively; after 9 months: χ2=4.568 and 6.258 respectively, P=0.033 and 0.012 respectively). Conclusion The home management manual for renal anemia can teach and remined PD patients and their family members to use EPO, and can help medical professionals adjust and follow up the use of EPO in PD patients. This manual is effective in the management of anemia in PD patients and deserves to be widely used clinically.
    Metrics
    Epidemiological investigation of maintenance hemodialysis patients in Shanxi province
    2020, 19 (03):  209-212.  doi: 10.3969/j.issn.1671-4091.2020.03.017
    Abstract ( 274 )   PDF (370KB) ( 891 )  
    【Abstract】Objective To investigate and analyze the current situation of maintenance hemodialysis (MHD) patients in Shanxi province. Methods We retrospectively studied clinical records of MHD patients in Shanxi province between January 2015 and December 2018. Results From 2015 to 2018, the age at which MHD begins was 40 to 69 years. The top three primary causes leading to MHD were glomerulonephritis (48.6%), diabetic nephropathy (27.9%) and hypertensive nephrosclerosis (10.2%). The first-used vascular access at the beginning of hemodialysis was arteriovenous fistula (49.8%) and primary non- cuffed catheter
    (41.8%). Albumin, urea reduction ratio (UUR) and urea removal index (Kt/V) reached to the standards were found in more than 80% of the patients, but serum calcium, phosphorus and intact parathyroid hormone reached to the standards were low(<60%). Cardiovascular and cerebrovascular events were the leading causes of death. Conclusion Most MHD patients in Shanxi province were middle- aged. The first three primary causes of MHD patients were glomerulonephritis, diabetic nephropathy, and hypertensive nephrosclerosis. The major vascular access at the beginning of hemodialysis was arteriovenous fistula. The control rate of complications was low in MHD patients.
    Metrics
    Clinical characteristics of Bacillus cereus induced peritoneal dialysis related peritonitis: report of a case and review of the literature
    2020, 19 (03):  213-215.  doi: 10.3969/j.issn.1671-4091.2020.03.018
    Abstract ( 267 )   PDF (335KB) ( 811 )  
    【Abstract】Objective To investigate clinical characteristics of peritoneal dialysis related peritonitis (PDRP) caused by Bacillus cereus. Methods The clinical data of a patient diagnosed as PDRP caused by a rare pathogen of Bacillus cereus was retrospectively analyzed. The related literature was reviewed. Results This patient experienced series episodes of PDRP and finally Bacillus cereus was isolated in peritoneal fluid. The PDRP was cured by prolonged treatment of sensitive antibiotics. Bacillus cereus caused PDRP mainly by pollution. It can be cured by effective antibiotics. However, relapse or repeat peritonitis was common, and removal of the catheter was considered to be an option for treatment. Conclusion Although rare to be seen, clinicians should be aware of Bacillus cereusas as the pathogen of PDRP. Appropriate treatment is useful to improve the patient’s outcome.
    Metrics